IN2014DN10706A - - Google Patents
Info
- Publication number
- IN2014DN10706A IN2014DN10706A IN10706DEN2014A IN2014DN10706A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A IN 10706DEN2014 A IN10706DEN2014 A IN 10706DEN2014A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A
- Authority
- IN
- India
- Prior art keywords
- skin patch
- improved
- drug
- adhesive strength
- organic solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012139215 | 2012-06-20 | ||
| PCT/JP2013/066765 WO2013191187A1 (ja) | 2012-06-20 | 2013-06-18 | 薬剤と有機溶媒と親油性膏体基剤と粉体を配合した貼付製剤組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10706A true IN2014DN10706A (xx) | 2015-09-04 |
Family
ID=49768781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10706DEN2014 IN2014DN10706A (xx) | 2012-06-20 | 2013-06-18 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10543275B2 (xx) |
| EP (1) | EP2865376B2 (xx) |
| JP (1) | JP6309892B2 (xx) |
| CN (3) | CN110693859A (xx) |
| AU (1) | AU2013278403B2 (xx) |
| BR (1) | BR112014031701A2 (xx) |
| CA (1) | CA2875454C (xx) |
| DK (1) | DK2865376T4 (xx) |
| ES (1) | ES2738303T5 (xx) |
| HU (1) | HUE045479T2 (xx) |
| IN (1) | IN2014DN10706A (xx) |
| PL (1) | PL2865376T5 (xx) |
| PT (1) | PT2865376T (xx) |
| SI (1) | SI2865376T1 (xx) |
| TR (1) | TR201911328T4 (xx) |
| WO (1) | WO2013191187A1 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3045166B1 (en) * | 2013-09-11 | 2020-12-16 | MEDRx Co., Ltd. | Novel base composition for tape agent |
| CN103830206B (zh) * | 2014-02-26 | 2016-08-31 | 上海现代药物制剂工程研究中心有限公司 | 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法 |
| JPWO2015129527A1 (ja) * | 2014-02-27 | 2017-03-30 | 株式会社 メドレックス | プラミペキソールを含有する神経変性疾患の治療用貼付剤 |
| WO2016109483A1 (en) * | 2014-12-30 | 2016-07-07 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for agomelatine |
| US10016502B2 (en) | 2015-08-29 | 2018-07-10 | Medrx Co., Ltd | Patch preparation containing an acid scavenger |
| WO2017037813A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| WO2017037812A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 酸捕捉剤を含有する貼付製剤 |
| US20170273974A1 (en) | 2016-03-24 | 2017-09-28 | Medrx Co., Ltd | Patch preparations with misuse prevention features |
| ES2957234T3 (es) * | 2016-03-24 | 2024-01-15 | Medrx Co Ltd | Preparación de parche con características de prevención del uso incorrecto de sustancias |
| US11642247B2 (en) | 2016-11-09 | 2023-05-09 | Kuraray Co., Ltd. | Pressure-sensitive adhesive sheet, adhesive bandage, and method of producing the same |
| US20220016061A1 (en) * | 2018-10-04 | 2022-01-20 | Medrx Co., Ltd. | Preparation Stabilized by Means of Nonaqueous Solvent |
| JP7179212B1 (ja) * | 2022-05-02 | 2022-11-28 | 久光製薬株式会社 | リドカイン含有貼付剤 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3144895B2 (ja) | 1992-06-30 | 2001-03-12 | 積水化学工業株式会社 | 医療用粘着テープもしくはシート |
| JPH06145050A (ja) * | 1992-11-11 | 1994-05-24 | Sekisui Chem Co Ltd | 貼付剤の製造方法 |
| JPH07145047A (ja) * | 1993-11-25 | 1995-06-06 | Sekisui Chem Co Ltd | 局所麻酔用経皮吸収テープ |
| JPH0827003A (ja) * | 1994-07-22 | 1996-01-30 | Sekisui Chem Co Ltd | 経皮吸収製剤 |
| JPH09169636A (ja) | 1995-06-12 | 1997-06-30 | Sekisui Chem Co Ltd | 貼付剤 |
| JPH09136834A (ja) | 1995-11-14 | 1997-05-27 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
| JP4648518B2 (ja) * | 2000-06-01 | 2011-03-09 | 帝國製薬株式会社 | ４−ビフェニル酢酸含有貼付剤 |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| US6503532B1 (en) * | 2001-04-13 | 2003-01-07 | Murty Pharmaceuticals, Inc. | Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof |
| AU2003272878A1 (en) * | 2002-09-13 | 2004-04-30 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| JP4629578B2 (ja) * | 2003-01-22 | 2011-02-09 | ニチバン株式会社 | 眼疾患治療用経皮吸収型製剤 |
| US8080261B2 (en) * | 2004-09-30 | 2011-12-20 | Teikoku Pharma Usa, Inc. | 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same |
| WO2008032719A1 (fr) * | 2006-09-11 | 2008-03-20 | Sekisui Chemical Co., Ltd. | Préparation adhésive |
| ATE545412T1 (de) * | 2006-09-11 | 2012-03-15 | Sekisui Chemical Co Ltd | Klebende zubereitung mit desglymidodrin |
| CN101909651B (zh) * | 2007-11-22 | 2013-11-06 | 美德阿利克斯株式会社 | 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物 |
| EP2258396B1 (en) | 2008-03-03 | 2017-09-06 | Hisamitsu Pharmaceutical Co., Inc. | Transdermally absorbable preparation |
| JP4822032B2 (ja) | 2009-01-08 | 2011-11-24 | タイヨーエレック株式会社 | 組合せ式遊技機 |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| DE102009022915A1 (de) * | 2009-05-27 | 2010-12-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit gesteuertem Wirkstofffluss |
| JP2011074035A (ja) * | 2009-09-30 | 2011-04-14 | Sekisui Medical Co Ltd | 貼付剤 |
-
2013
- 2013-06-18 WO PCT/JP2013/066765 patent/WO2013191187A1/ja active Application Filing
- 2013-06-18 IN IN10706DEN2014 patent/IN2014DN10706A/en unknown
- 2013-06-18 CN CN201911053677.0A patent/CN110693859A/zh active Pending
- 2013-06-18 CA CA2875454A patent/CA2875454C/en active Active
- 2013-06-18 CN CN201810750500.5A patent/CN108553452A/zh active Pending
- 2013-06-18 AU AU2013278403A patent/AU2013278403B2/en not_active Ceased
- 2013-06-18 EP EP13806076.9A patent/EP2865376B2/en active Active
- 2013-06-18 CN CN201380031729.9A patent/CN104363900A/zh active Pending
- 2013-06-18 TR TR2019/11328T patent/TR201911328T4/tr unknown
- 2013-06-18 US US14/408,649 patent/US10543275B2/en active Active
- 2013-06-18 DK DK13806076.9T patent/DK2865376T4/da active
- 2013-06-18 PL PL13806076.9T patent/PL2865376T5/pl unknown
- 2013-06-18 SI SI201331532T patent/SI2865376T1/sl unknown
- 2013-06-18 ES ES13806076T patent/ES2738303T5/es active Active
- 2013-06-18 PT PT13806076T patent/PT2865376T/pt unknown
- 2013-06-18 HU HUE13806076A patent/HUE045479T2/hu unknown
- 2013-06-18 JP JP2014521482A patent/JP6309892B2/ja active Active
- 2013-06-18 BR BR112014031701A patent/BR112014031701A2/pt not_active Application Discontinuation
-
2019
- 2019-09-09 US US16/564,587 patent/US12016924B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK2865376T3 (da) | 2019-08-12 |
| SI2865376T1 (sl) | 2019-11-29 |
| DK2865376T4 (da) | 2022-07-18 |
| ES2738303T3 (es) | 2020-01-21 |
| US10543275B2 (en) | 2020-01-28 |
| EP2865376A4 (en) | 2015-11-18 |
| PL2865376T3 (pl) | 2019-12-31 |
| ES2738303T5 (es) | 2022-09-12 |
| CN104363900A (zh) | 2015-02-18 |
| US20150174249A1 (en) | 2015-06-25 |
| TR201911328T4 (tr) | 2019-08-21 |
| CA2875454A1 (en) | 2013-12-27 |
| JPWO2013191187A1 (ja) | 2016-05-26 |
| PL2865376T5 (pl) | 2023-01-09 |
| AU2013278403B2 (en) | 2018-02-01 |
| CA2875454C (en) | 2021-02-16 |
| AU2013278403A1 (en) | 2015-01-22 |
| EP2865376B1 (en) | 2019-06-05 |
| WO2013191187A1 (ja) | 2013-12-27 |
| PT2865376T (pt) | 2019-08-26 |
| CN110693859A (zh) | 2020-01-17 |
| BR112014031701A2 (pt) | 2017-06-27 |
| EP2865376A1 (en) | 2015-04-29 |
| US20190388544A1 (en) | 2019-12-26 |
| JP6309892B2 (ja) | 2018-04-11 |
| US12016924B2 (en) | 2024-06-25 |
| CN108553452A (zh) | 2018-09-21 |
| HUE045479T2 (hu) | 2019-12-30 |
| EP2865376B2 (en) | 2022-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN10706A (xx) | ||
| MX2015013727A (es) | Composicion para preparacion de uso externo con permeabilidad transdermica mejorada. | |
| PH12015500115A1 (en) | Glucagon analogues | |
| HK1204784A1 (zh) | 包含至少種碱土金屬碳酸氫鹽的水溶液的製備方法及其用途 | |
| HUE044118T2 (hu) | Hatóanyagként ektoint vagy hidroxiektoint tartalmazó készítmény sérült testszövetek regenerálódásának gyorsítására | |
| WO2013142611A3 (en) | Silk reservoirs for drug delivery | |
| EP3088426A4 (en) | Compound containing mesogenic group, and mixture, composition, and optically anisotropic body using said compound | |
| HRP20160888T1 (hr) | Postupak za pripremanje vodene otopine koja sadrži barem jedan zemnoalkalijski hidrogenkarbonat te njezina uporaba | |
| SG195086A1 (en) | Compounds containing hydrido-tricyano-borate anions | |
| IN2015DN01165A (xx) | ||
| IN2015DN01164A (xx) | ||
| FI20110371A0 (fi) | Veden pihkaseoskoostumus (dispersio) käytettäväksi antimikrobisena lääketieteellisenä hoitoaineena ja antimikrobisena lisäaineena vesiohenteisissa liuoksissa sekä teknillisissä materiaaleissa | |
| MX369244B (es) | Solucion alcoholica estable de alprostadilo. | |
| CL2014003282A1 (es) | Uso de cetal como solvente en adhesivos y composición adhesiva que contiene cetal. | |
| MX2013002446A (es) | Derivados de tetrahidropirrolopirazina sustituidos. | |
| ZA201405920B (en) | Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use | |
| ZA201405302B (en) | Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use | |
| AU2012901130A0 (en) | A composition and method for enhancing the permeability of a tissue of a subject to an active agent | |
| ZA201407279B (en) | Aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid |